35 Einträge gefunden

1. p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer

   1. Lebok, Patrick
   2. Roming, Magdalena
   3. Kluth, Martina
   4. Koop, Christina
   5. Ozden, Cansu
   6. Taskin, B
   7. Hussein, K

   2016 - Forschungsinformationssystem des UKE
2. Loss of membranous VEGFR1 expression is associated with an adverse phenotype and shortened survival in breast cancer

   1. Lebok, Patrick
   2. Huber, Julia
   3. Burandt, Eike-Christian
   4. Lebeau, Annette
   5. Marx, Andreas Holger
   6. Terracciano, Luigi
   7. Heilenkötter, Uwe

   2016 - Forschungsinformationssystem des UKE
3. Cyclin D1 gene amplification is highly homogeneous in breast cancer

   1. Burandt, Eike
   2. Grünert , Martin
   3. Lebeau, Annette
   4. Choschzick, Matthias
   5. Quaas, Alexander
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2016 - Forschungsinformationssystem des UKE
4. High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer

   1. Lebok, Patrick
   2. Öztürk, Eray
   3. Heilenkötter, Uwe
   4. Jaenicke, Fritz
   5. Müller, Volkmar
   6. Paluchowski, Peter
   7. Geist, Stefan

   2016 - Forschungsinformationssystem des UKE
5. Schnell wachsender Mammatumor der Stillphase

   1. Pöhler, M
   2. Hanslik, M
   3. Nemitz, S
   4. Bürrig, K.-F.
   5. Mentzel, T.
   6. Lebeau, Annette

   2014 - Forschungsinformationssystem des UKE
6. Mammographie-Screening. Ist was dran an der Kritik?

   1. Lebeau, Annette
   2. Heywang-Köbrunner, Sylvia H
   3. Katalinic, Alexander

   2014 - Forschungsinformationssystem des UKE
7. Loss of ALCAM expression is linked to adverse phenotype and poor prognosis in breast cancer: a TMA-based immunohistochemical study on 2,197 breast cancer patients

   1. Burandt, Eike
   2. Bari Noubar, Tanaz
   3. Lebeau, Annette
   4. Minner, Sarah
   5. Burdelski, Christoph
   6. Jänicke, Fritz
   7. Müller, Volkmar

   2014 - Forschungsinformationssystem des UKE
8. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.

   1. Kuehn, Thorsten
   2. Bauerfeind, Ingo
   3. Fehm, Tanja
   4. Fleige, Barbara
   5. Hausschild, Maik
   6. Helms, Gisela
   7. Lebeau, Annette

   2013 - Forschungsinformationssystem des UKE
9. German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer

   1. Hoffmann, Jürgen
   2. Souchon, Rainer
   3. Lebeau, Annette
   4. Öhlschlegel, Christian
   5. Gruber, Günther
   6. Rageth, Christoph
   7. Weber, Walter

   2013 - Forschungsinformationssystem des UKE
10. [Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines].

    1. Lebeau, Annette
    2. Kreipe, H
    3. Dietel, M
    4. Schlake, W
    5. Kreienberg, R

    2013 - Forschungsinformationssystem des UKE
11. Rare oncogenic mutations of predictive markers for targeted therapy in triple-negative breast cancer.

    1. Grob, Tobias
    2. Heilenkötter, Uwe
    3. Geist, Stefan
    4. Paluchowski, Peter
    5. Wilke, Christian
    6. Jänicke, Fritz
    7. Quaas, Alexander

    2012 - Forschungsinformationssystem des UKE
12. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.

    1. Untch, Michael
    2. Fasching, Peter A
    3. Konecny, Gottfried E
    4. Hasmüller, Stephan
    5. Lebeau, Annette
    6. Kreienberg, Rolf
    7. Camara, Oumar

    2011 - Forschungsinformationssystem des UKE
13. Reliability of human epidermal growth factor receptor 2 immunohistochemistry in breast core needle biopsies.

    1. Lebeau, Annette
    2. Turzynski, Andreas
    3. Braun, Susanne
    4. Behrhof, Wera
    5. Fleige, Barbara
    6. Schmitt, Wolfgang D
    7. Grob, Tobias

    2010 - Forschungsinformationssystem des UKE
14. Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer.

    1. Schwarz, Jörg
    2. Tiling, R
    3. Avril-Sassen, S
    4. Mahner, Sven
    5. Lebeau, Annette
    6. Weber, Christoph
    7. Schwaiger, M

    2010 - Forschungsinformationssystem des UKE
15. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation.

    1. Choschzick, Matthias
    2. Bacher, Ulrike
    3. Ayuketang Ayuk, Francis
    4. Lebeau, Annette

    2010 - Forschungsinformationssystem des UKE
16. PPFIA1 and CCND1 are frequently coamplified in breast cancer.

    1. Dancau, Ana Maria
    2. Wuth, Laura
    3. Waschow, Marcel
    4. Holst, Frederik
    5. Krohn, Antje
    6. Choschzick, Matthias
    7. Terracciano, Luigi

    2010 - Forschungsinformationssystem des UKE
17. Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome.

    1. Choschzick, Matthias
    2. Lassen, Paula
    3. Lebeau, Annette
    4. Marx, Andreas
    5. Terracciano, Luigi
    6. Heilenkötter, Uwe
    7. Jänicke, Fritz

    2010 - Forschungsinformationssystem des UKE
18. Monitoring primary systemic therapy of large and locally advanced breast cancer by using sequential positron emission tomography imaging with [18F]fluorodeoxyglucose.

    1. Schwarz-Dose, Jörg
    2. Untch, Michael
    3. Tiling, Reinhold
    4. Sassen, Stefanie
    5. Mahner, Sven
    6. Kahlert, Steffen
    7. Harbeck, Nadia

    2009 - Forschungsinformationssystem des UKE
19. Overexpression of cell division cycle 7 homolog is associated with gene amplification frequency in breast cancer.

    1. Choschzick, Matthias
    2. Lebeau, Annette
    3. Marx, Andreas
    4. Tharun, Lars
    5. Terracciano, Luigi
    6. Heilenkötter, Uwe
    7. Jänicke, Fritz

    2009 - Forschungsinformationssystem des UKE
20. Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer.

    1. Untch, Michael
    2. Möbus, Volker
    3. Kuhn, Walther
    4. Muck, Bernd Rudolph
    5. Thomssen, Christoph
    6. Bauerfeind, Ingo
    7. Harbeck, Nadia

    2009 - Forschungsinformationssystem des UKE